Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 22496383)

1.

Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort.

Murdoch TB, Bernstein CN, El-Gabalawy H, Stempak JM, Sargent M, Elias B, Xu W, Pathan S, Silverberg MS.

CMAJ. 2012 May 15;184(8):E435-41. doi: 10.1503/cmaj.110613. Epub 2012 Apr 10. Erratum in: CMAJ. 2012 Jul 10;184(10):1176.

2.

Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Rigoli L, Romano C, Caruso RA, Lo Presti MA, Di Bella C, Procopio V, Lo Giudice G, Amorini M, Costantino G, Sergi MD, Cuppari C, Calabro GE, Gallizzi R, Salpietro CD, Fries W.

World J Gastroenterol. 2008 Jul 28;14(28):4454-61.

3.

Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.

Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.

Am J Gastroenterol. 2009 Jul;104(7):1723-33. doi: 10.1038/ajg.2009.184. Epub 2009 May 19.

PMID:
19455129
4.

CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.

van der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, de Rooij FW.

Eur J Gastroenterol Hepatol. 2007 Jun;19(6):449-59. Review.

PMID:
17489054
5.

Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.

Murdoch TB, Xu W, Stempak JM, Landers C, Targan SR, Rotter JI, Silverberg MS.

Inflamm Bowel Dis. 2012 Sep;18(9):1743-8. doi: 10.1002/ibd.22884. Epub 2012 Jan 24.

6.

Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population.

Kanaan ZM, Eichenberger MR, Ahmad S, Weller C, Roberts H, Pan J, Rai SN, Petras R, Weller EB Jr, Galandiuk S.

J Negat Results Biomed. 2012 Jan 23;11:7. doi: 10.1186/1477-5751-11-7.

7.

NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.

Ozen SC, Dagli U, Kiliç MY, Törüner M, Celik Y, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Bozdayi AM.

J Gastroenterol. 2006 Apr;41(4):304-10.

PMID:
16741608
8.

Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease.

Esters N, Pierik M, van Steen K, Vermeire S, Claessens G, Joossens S, Vlietinck R, Rutgeerts P.

Am J Gastroenterol. 2004 Feb;99(2):299-305.

PMID:
15046221
9.

Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy.

Latiano A, Palmieri O, Valvano MR, D'Incà R, Cucchiara S, Riegler G, Staiano AM, Ardizzone S, Accomando S, de Angelis GL, Corritore G, Bossa F, Annese V.

World J Gastroenterol. 2008 Aug 7;14(29):4643-51.

10.

IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.

Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, Timms KM, Gutin A, Lanchbury JS, Merriman TR, Barclay ML, Kennedy MA.

Am J Gastroenterol. 2007 Dec;102(12):2754-61. Epub 2007 Sep 25.

PMID:
17894849
11.

The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease.

Hradsky O, Dusatkova P, Lenicek M, Bronsky J, Nevoral J, Vitek L, Lukas M, Zeniskova I, Cinek O.

BMC Med Genet. 2010 Jun 10;11:91. doi: 10.1186/1471-2350-11-91.

12.

Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.

Latiano A, Palmieri O, Corritore G, Valvano MR, Bossa F, Cucchiara S, Castro M, Riegler G, De Venuto D, D'Incà R, Andriulli A, Annese V.

Inflamm Bowel Dis. 2010 Jul;16(7):1108-17. doi: 10.1002/ibd.21176.

PMID:
20024904
13.

Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.

Okazaki T, Wang MH, Rawsthorne P, Sargent M, Datta LW, Shugart YY, Bernstein CN, Brant SR.

Inflamm Bowel Dis. 2008 Nov;14(11):1528-41. doi: 10.1002/ibd.20512. Erratum in: Inflamm Bowel Dis. 2012 Aug;18(8):1591.

14.

The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.

Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L, Pfennig S, Haller D, Griga T, Klein W, Epplen JT, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Mussack T, Folwaczny M, Müller-Myhsok B, Brand S.

Am J Gastroenterol. 2008 Mar;103(3):682-91. Epub 2007 Dec 20.

PMID:
18162085
16.

Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.

Mahurkar S, Banerjee R, Rani VS, Thakur N, Rao GV, Reddy DN, Chandak GR.

J Gastroenterol Hepatol. 2011 Apr;26(4):694-9. doi: 10.1111/j.1440-1746.2010.06533.x.

PMID:
21155887
17.

P268S in NOD2 associates with susceptibility to Parkinson's disease in Chinese population.

Ma Q, An X, Li Z, Zhang H, Huang W, Cai L, Hu P, Lin Q, Tzeng CM.

Behav Brain Funct. 2013 May 7;9:19. doi: 10.1186/1744-9081-9-19.

18.

Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort.

Lv C, Yang X, Zhang Y, Zhao X, Chen Z, Long J, Zhang Y, Zhong C, Zhi J, Yao G, Jiang B, Zhi F.

Int J Colorectal Dis. 2012 Nov;27(11):1465-72. doi: 10.1007/s00384-012-1450-6. Epub 2012 Mar 20.

PMID:
22426692
19.

Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort.

Gearry RB, Roberts RL, Burt MJ, Frampton CM, Chapman BA, Collett JA, Shirley P, Allington MD, Kennedy MA, Barclay ML.

Inflamm Bowel Dis. 2007 Oct;13(10):1220-7.

PMID:
17538984
20.

ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients.

Lakatos PL, Szamosi T, Szilvasi A, Molnar E, Lakatos L, Kovacs A, Molnar T, Altorjay I, Papp M, Tulassay Z, Miheller P, Papp J, Tordai A, Andrikovics H; Hungarian IBD Study Group.

Dig Liver Dis. 2008 Nov;40(11):867-73. doi: 10.1016/j.dld.2008.03.022. Epub 2008 May 22.

PMID:
18499543
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk